A rising related-substance total over six months: degradation or method drift? posts 31–43
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Picking up post #29: that is the part I would want checked first.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the monomer on HPLC depending on the method.
I read post #33 twice before replying, because I had assumed the opposite.
Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species appear. Reducing conditions (like DTT) convert them back.
This follows post #33 rather than contradicting it.
Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area percent. How related they can be before they exceed specification is a regulatory question.
Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be stated separately from the purity.
Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the residue's hydrophobicity. They are the most common impurity in solid-phase synthesis.
Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural isomer with the same mass but a different sequence. No chromatographic purity method detects this without a reference standard.
This follows post #38 rather than contradicting it.
Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if antioxidants are not present.
Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Endotoxin and why it is a separate question from purity
Endotoxin and why it is a separate question from purity Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
2 | 22k | 4mo | |
|
Oxidation pathways for methionine and tryptophan
Posting this under the heading it deserves: Oxidation pathways for methionine and tryptophan Everything below is what sits behind that. Working through the identity arithmetic and I would like it checked.…
|
+58 | 63 | 1k | 19mo |
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
+11 | 15 | 825 | 2d |
|
Follow-up: Attributing a new peak: degradation product or excipient?
Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+15 | 19 | 671 | 17mo |
|
[2026 update] A rising related-substance total over six months: degradation or method drift?
The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody repeats it. Posting the method first, because…
|
+71 | 78 | 34k | 5mo |
Related topics — sharing the tags data table, endotoxin testing, HPLC
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Circumference measurements as a poor man's composition estimate
Posting this under the heading it deserves: Circumference measurements as a poor man's composition estimate Everything below is what sits behind that. Longitudinal report with the method stated, because a…
|
+96 | 112 | 14k | 23mo |
|
Contributing data without breaching anyone's privacy
Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
+65 | 71 | 839 | 5mo |
|
Area percent versus weight percent: the confusion that causes most arguments
Posting this under the heading it deserves: Area percent versus weight percent: the confusion that causes most arguments Everything below is what sits behind that. Posting the method first, because I know…
|
+10 | 14 | 2.1k | 2mo |
|
Revisiting: Bioimpedance and hydration: why the number moves
Posting this under the heading it deserves: Revisiting: Bioimpedance and hydration: why the number moves Everything below is what sits behind that. Longitudinal report with the method stated, because a number…
|
2 | 2.8k | 1mo | |
|
Follow-up: Attributing a new peak: degradation product or excipient?
Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+15 | 19 | 671 | 17mo |